Document Type : Original Article


1 Department of Biology, Qom Branch, Islamic Azad University, Qom, Iran.

2 Department of Biology, Qom Branch, Islamic Azad University, Qom, Iran

3 Department of Biology, Damghan Branch, Islamic Azad University, Semnan, Iran.

4 Department of Biotechnology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.



Microorganisms attach to various surfaces and they have manufactured biofilms by production polysaccharides like PSL in P.aeruginosa. synthesis of this kind of polysaccharide has done by PSL gene cluster. The aim of this study is consideration biofilm formation which is one of the major cause antibiotic resistance
In this study, 100 P. aeruginosa were isolated with bacteriological and biochemical methods and pslA gene detection with PCR in all of the P. aeruginosa isolated from patients Then biofilm formation checked with microtiter plate method and it showed with SEM. Finally, expression of main attachment gene pslA in 6 strains could make moderate and strong biofilm were investigated by real-time PCR assay.
In this study, 100 P. aeruginosa were isolated that these strains showed High rates of MDR. The presence pslA gene in all of the pseudomonas isolated from patients was proven. Microtiter plate method showed 24 (24%) strains could make biofilm Among 100 strains that showed with SEM. The pslA expression in strains which making moderate and strong biofilms are more than other strains
Hence, for bacterial biofilm treatment is recommended: Before antibiotics are prescribed, biofilm formation by bacteria should be investigated.


Abidi, SH, Sherwani, SK, Siddiqui, TR, Bashir, A, Kazmi, SU. (2013). Drug resistance profile and biofilm-forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol., 13(1):57.
Brandenburg, KS, Calderon, DF, Kierski, PR, Brown, AL, Shah, NM, Abbott, NL, Schurr, MJ, Murphy, CJ, McAnulty, JF, Czuprynski, CJ. (2015). Inhibition of Pseudomonas aeruginosa biofilm formation on wound dressings. Wound Repair. Regen., 23(6):842-854.
Buhl, M, Peter, S, Willmann, M. (2015). Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review. Expert Rev. Anti Infect Ther., 13(9):1159-1170.
Fratesi, SE, Lynch, FL, Kirkland, BL, Brown, LR. (2004). Effects of SEM preparation techniques on the appearance of bacteria and biofilms in the Carter Sandstone. J. Sediment. Res., 74(6):858-867.
Hassan, A, Usman, J, Kaleem, F, Omair, M, Khalid, A, Iqbal, M. (2011). Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz. J. Infect Dis., 15(4):305-311.
Khan, W, Bernier, SP, Kuchma, SL, Hammond, JH, Hasan, F, O’Toole, GA. (2010). Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide. Int. Microbiol., 13(4):207.
Kolter, R. (2010). Biofilms in lab and nature: a molecular geneticist’s voyage to microbial ecology. Int. Microbiol., 13(7):1-7
Laverty, G, Gorman, S, Gilmore, B. (2014). Biomolecular mechanisms of Pseudomonas aeruginosa and Escherichia coli biofilm formation. Pathogens., 3(3):596-632.
Naves, P, Del Prado, G, Huelves, L, Gracia M, Ruiz, V, Blanco, J, Rodríguez-Cerrato, V, Ponte, MC, Soriano, F. (2008). Measurement of biofilm formation by clinical isolates of Escherichia coli is method‐dependent. J. Appl. Microbiol., 105(2):585-590.
Overhage, J, Schemionek, M, Webb, JS, Rehm, BH. (2005). Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm formation. Appl. Environ. Microbiol., 71(8):4407-4413.
Peleg, AY, Hooper, DC. (2010). Hospital-acquired infections due to gram-negative bacteria. N. Engl. J. Med., 362(19):1804-1813.
Perez, LRR, Costa, MCN, Freitas, ALP, Barth, AL. (2011). Evaluation of biofilm production by Pseudomonas aeruginosa isolates recovered from cystic fibrosis and non-cystic fibrosis patients. Braz. J. Microbiol., 42(2):476-479.
Porras-Gómez, M, Vega-Baudrit, J, Núñez-Corrales, S. (2012). Overview of multidrug-resistant Pseudomonas aeruginosa and novel therapeutic approaches. J. Biomater. Nanobiotechnol., 3(04):519.
Seshadri, S, Chhatbar, C. (2009). Multidrug resistance in Pseudomonas aeruginosa: Insights into the molecular mechanisms. Afr. J. Microbiol. Res., 3(5):195-199.
Shahandashti, EF, Molana, Z, Asgharpour, F, Mojtahedi, A, Rajabnia, R. (2012). Molecular detection of Integron genes and pattern of antibiotic resistance in Pseudomonas aeruginosa strains isolated from intensive care unit, Shahid Beheshti Hospital, North of Iran. Int. J. Mol. Cell. Med., 1(4):209.
Verma, U, Kulshreshtha, S, Khatri, P. (2018). MDR Pseudomonas aeruginosa in nosocomial infection: burden in ICU and burn units of a tertiary care hospital. Int. J. Curr. Microbiol. Appl. Sci., 7:1267-1274.
Wei, Q, Ma, L. (2013). Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int. J. Mol. Sci., 14(10):20983-21005.
Zaidenstein, R, Miller, A, Tal-Jasper, R, Ofer-Friedman, H, Sklarz, M, Katz, DE, Lazarovitch, T, Lephart, PR, Mengesha, B, Tzuman, O, Dadon, M, Daniel, C, Moran-Gilad, J, Marchaim, D. (2018). Therapeutic Management of Pseudomonas aeruginosa Bloodstream Infection Non-Susceptible to Carbapenems but Susceptible to “Old” Cephalosporins and/or to Penicillins. Microorganisms., 6(1):9.